Francis Peyton Rous: The discovery that laid the foundations of viral oncology

“Rous is credited for identifying a transmissible agent responsible for sarcoma in chickens, a discovery that laid the foundation for the field of viral oncology.”

BUFFALO, NY- October 28, 2026 – A new review was published in Volume 17 of Genes & Cancer on October 23, 2026, titled “The life and legacy of Francis Peyton Rous: The birth of viral oncology.”

The review explores the life and scientific achievements of Francis Peyton Rous, whose pioneering experiments demonstrated that a cancer-causing agent could be transmitted between chickens. His discovery challenged established ideas about cancer and helped lay the foundation for viral oncology, oncogene research and the modern understanding of cancer as a genetic disease. The article also examines his contributions to blood preservation, experimental carcinogenesis and scientific publishing.

The review was led by first author Pratiba Irudayaraj, affiliated with the University of Arkansas at Little Rock. Corresponding authors Nawab Ali and Krishnaswamy Kannan are affiliated with the University of Arkansas at Little Rock and Biomolecular Integrations Inc., Little Rock, Arkansas, respectively.

Today, scientists recognize that certain viruses can contribute to cancer development by altering cellular signaling, interfering with tumor-suppressor pathways or promoting chronic inflammation. However, at the beginning of the twentieth century, cancer was largely considered a disease arising from abnormalities within cells rather than infectious agents. Rous's research helped transform this understanding by demonstrating that an external biological agent could initiate malignant tumor formation.

Born in Baltimore, Maryland, in 1879, Rous developed an early interest in natural history and scientific observation. He studied at Johns Hopkins University, earning his medical degree in 1905, and later pursued pathology research at the University of Michigan and further training in Germany. His scientific approach was shaped by mentors who emphasized careful observation, accurate diagnosis and experimental rigor.

In 1909, Rous joined the Rockefeller Institute for Medical Research, where he was asked to investigate cancer. That same year, a poultry farmer brought him a Barred Plymouth Rock hen with a breast tumor. Rous examined the growth and identified it as a spindle-cell sarcoma, an aggressive malignancy arising from connective tissue.

What began as the examination of an unusual chicken tumor developed into experiments that would change cancer biology. Rous initially transplanted tumor tissue into other chickens, observing successful growth in genetically related birds but not in unrelated animals. These findings highlighted the importance of host compatibility and encouraged further investigation into how the tumor could spread.

The decisive breakthrough came when Rous tested whether tumor transmission required living cancer cells. He ground tumor tissue in solution, separated the liquid component and passed it through a Berkefeld filter designed to retain bacteria and intact cells. When the resulting cell-free filtrate was injected into healthy chickens of a closely related strain, new tumors developed.

These experiments, reported in 1910–1911, demonstrated that a filterable agent could transmit malignant disease without transferring intact tumor cells. The agent was later identified as Rous sarcoma virus (RSV), an avian retrovirus capable of transforming infected cells into cancer cells.

The discovery challenged prevailing assumptions about cancer. Although Rous could not identify the virus using modern molecular techniques, his experiments established a new explanation for how certain malignancies could arise.

Despite the significance of his findings, many scientists remained skeptical. No human cancer had yet been conclusively linked to a virus, and researchers questioned whether observations in chickens were relevant to human disease. Limited experimental technologies also made it difficult to explain how the agent caused tumors. Rous nevertheless maintained confidence in his observations, supported by careful documentation and reproducible evidence.

During the years when his cancer research received limited recognition, Rous expanded his investigations into other medical fields. Working with J. R. Turner during 1915–1916, he developed the Rous–Turner solution, a citrate-sugar preparation that allowed red blood cells to be preserved for extended periods.

This innovation contributed to the development of blood storage and transfusion practices, including early wartime blood banks. Although the original formulation was later replaced, its principles of citrate anticoagulation and glucose-supported red blood cell preservation remain important in modern transfusion medicine.

Rous also returned to cancer research through studies of rabbit papillomaviruses and chemical carcinogenesis. His investigations examined how viral infection and chemical agents could interact during tumor development. In work with William F. Friedewald in 1944, he helped clarify the distinction between tumor initiation and promotion, contributing to the understanding that cancer develops through multiple biological stages.

Meanwhile, advances in cell culture and molecular biology began revealing the broader significance of RSV. In the 1950s, Howard Temin and Harry Rubin developed experimental assays that allowed researchers to measure virus-induced cellular transformation in culture. These methods moved tumor virology beyond animal experiments and made the underlying mechanisms easier to investigate.

Another breakthrough came with the discovery of reverse transcriptase by Temin and David Baltimore in 1970. This enzyme allows retroviruses to convert RNA into DNA, which can then integrate into the host genome. The finding explained a fundamental step in retroviral replication and helped researchers understand how viral genetic information could persist within infected cells.

Subsequent research identified the v-src gene as the transforming oncogene carried by RSV. Scientists later discovered that this viral gene was related to c-src, a normal cellular gene involved in regulating growth and signaling. This established a fundamental principle of cancer biology: genes that normally regulate cellular functions can become oncogenic when altered or improperly controlled.

Further investigations demonstrated that Src functions as a tyrosine kinase, an enzyme involved in transmitting signals that regulate cell growth, survival and other activities. These discoveries helped establish the importance of oncogenes, proto-oncogenes and abnormal signaling pathways in cancer development, providing a foundation for later advances in molecular oncology.

The review also traces how tumor virology contributed to understanding human cancers associated with infectious agents. Subsequent research identified cancer-related viruses, including human papillomavirus (HPV), hepatitis B virus (HBV), Epstein–Barr virus (EBV), human T-lymphotropic virus type 1 (HTLV-1) and Kaposi's sarcoma-associated herpesvirus (KSHV).

These discoveries contributed to cancer prevention and treatment strategies, particularly vaccination against HPV and HBV, which can prevent infections responsible for certain malignancies. However, the review presents Rous's contribution as foundational rather than suggesting that his original experiments directly produced modern therapies.

Recognition of Rous's achievement came decades after his initial discovery. In 1966, at the age of 87, he received the Nobel Prize in Physiology or Medicine for demonstrating that a filterable agent could induce malignant tumors in chickens. He shared the award with Charles Huggins, whose work established the hormonal responsiveness of prostate cancer.

The Nobel Prize came approximately 55 years after Rous's landmark experiments, reflecting the prolonged skepticism surrounding viral carcinogenesis. By then, RSV had become an important experimental model for cancer research, while later discoveries involving reverse transcriptase and the src oncogene further clarified the molecular mechanisms of cancer.

Beyond his laboratory research, Rous influenced biomedical publishing through his work at the Journal of Experimental Medicine. Beginning as co-editor in 1921, he later served as editor and remained involved until 1970. His commitment to clear scientific communication, experimental rigor and accurate attribution helped shape the journal and influence generations of researchers.

“What began with the investigation of a tumor-bearing chicken at the Rockefeller Institute therefore contributed to a chain of discoveries that profoundly changed our understanding of cancer biology and its molecular basis.”

The review highlights broader lessons from Rous's career, including the importance of scientific preparedness, meticulous recordkeeping, intellectual flexibility and persistence. His willingness to investigate an unexpected observation, despite limited technology and professional skepticism, demonstrates how careful experimentation can challenge established assumptions and open new research directions.

As a historical and scientific review, the article synthesizes historical accounts and subsequent research developments rather than presenting new experimental findings. The authors emphasize that Rous's original discovery became the starting point for a broader scientific effort involving many investigators who helped establish the molecular basis of cancer.

Overall, the review presents Francis Peyton Rous as a pioneering scientist whose curiosity, persistence and experimental rigor transformed cancer research. His demonstration that a filterable agent could cause malignant tumors established a foundation for viral oncology and the discovery of cellular oncogenes. More than a century later, his legacy continues to influence research into cancer mechanisms, prevention and molecularly targeted therapies.

Paper DOI: https://doi.org/10.18632/genesandcancer.245                 

Corresponding authors: Nawab Ali - nali@ualr.edu, Krishnaswamy Kannan krishna.kannan9900@gmail.com, (ORCID 0009-0008-7731-0572)  

Abstract video: https://www.youtube.com/watch?v=hfqgKkYp64k

Keywords: Francis Peyton Rous, Rous sarcoma virus, retrovirus, oncogenes, viral oncology

Click here to sign up for free Altmetric alerts about this article.

__________

To learn more about the journal, please visit www.GenesandCancer.com and connect with us on social media at:

• X 

• Facebook 

• YouTube 

• LinkedIn 

• Instagram

For media inquiries, please contact media@impactjournals.com.